Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-19T01:37:54.636Z Has data issue: false hasContentIssue false

8 - Laboratory investigation of platelets

Published online by Cambridge University Press:  15 October 2009

Gregory YH Lip
Affiliation:
University Department of Medicine, City Hospital, Birmingham, UK
Paolo Gresele
Affiliation:
Università degli Studi di Perugia, Italy
Valentin Fuster
Affiliation:
Mount Sinai School of Medicine, New York
Jose A. Lopez
Affiliation:
Seattle University
Clive P. Page
Affiliation:
King's College London
Jos Vermylen
Affiliation:
Katholieke Universiteit Leuven, Belgium
Get access

Summary

INTRODUCTION

There are numerous available laboratory methods for the assessment of platelets. These range from the quantification of platelet count and size to measurement of the bleeding time, platelet aggregation, and so forth (Table 8.1). Techniques applied include flow cytometry, point-of-care assessment devices (e.g., PFA-100®), and enzyme linked immunosorbent assay (ELISA) (e.g., laboratory markers of in vivo platelet activation). Other novel techniques for the study of platelets/megakaryocytes (MKs) are available, and include manipulation of gene expression in MKs, use of antisense oligonucleotides, green fluorescene protein (GFP) fusion proteins, mRNA and cDNA libraries from platelets or MKs, gene array technologies, etc. This chapter provides an overview of these techniques.

BLOOD SAMPLING

Accurate assessment of both platelet count and function can be highly dependent on the care and attention paid during both venipuncture and blood processing.

The donor should not be stressed and in the preceding week should not have had medications that may affect platelet function. A 19- to 20-gauge needle and plastic syringe should be used for venipuncture and the time from venipuncture to laboratory testing should be standardized, because loss of CO2 from the sample results in a rise in pH that generally increases platelet responsiveness to agonists. Hemolysis must be avoided, as lysed red blood cells liberate the platelet-aggregating agent ADP.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×